Influenza News and Research

Latest Influenza News and Research

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

What is the role of cyclophilin-A in alleviating SARS-CoV-2 infections?

2 Nov 2022
WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

1 Nov 2022
Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

Hybrid virus particles formed from coinfections exhibit immune evasion and expanded tropism

1 Nov 2022
What is the impact of SARS-CoV-2 on HIV-1 infectivity?

What is the impact of SARS-CoV-2 on HIV-1 infectivity?

31 Oct 2022
An innovative nasal vaccine strategy to combat COVID

An innovative nasal vaccine strategy to combat COVID

31 Oct 2022
An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

An estimated 15% of U.S. adults infected with SARS-CoV-2 have long-COVID

30 Oct 2022
Study reports on a novel property of antibodies, light chain coherence

Study reports on a novel property of antibodies, light chain coherence

30 Oct 2022
New insights on antibody response against SARS-CoV-2 Omiron sublineages

New insights on antibody response against SARS-CoV-2 Omiron sublineages

28 Oct 2022
The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

28 Oct 2022
In mild cases of COVID, blood clot risk is higher

In mild cases of COVID, blood clot risk is higher

27 Oct 2022
Third dose of COVID-19 mRNA vaccine offers cirrhosis patients strong protection against the virus

Third dose of COVID-19 mRNA vaccine offers cirrhosis patients strong protection against the virus

27 Oct 2022
Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

Rare variants of type I IFN immunity genes could underlie life-threatening COVID-19

27 Oct 2022
Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariants

27 Oct 2022
Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

Study reveals conserved and divergent host responses to infections with SARS-CoV-2 variants of concern

26 Oct 2022
SARS-CoV-2 BQ.1 variant cases may increase in Europe

SARS-CoV-2 BQ.1 variant cases may increase in Europe

26 Oct 2022
A review of emerging pediatric respiratory viruses

A review of emerging pediatric respiratory viruses

26 Oct 2022
Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

Did COVID-19 mitigation measures in the United Kingdom impact the transmission of other infectious diseases?

25 Oct 2022
Avian influenza virus introduced from Europe to North America through Iceland

Avian influenza virus introduced from Europe to North America through Iceland

25 Oct 2022
Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

Researchers design a COVID-19 vaccine construct using hybrid SARS-CoV-2 spike protein and nucleocapsid protein peptides

25 Oct 2022
What is the efficacy of mulberry component Kuwanon C against COVID-19?

What is the efficacy of mulberry component Kuwanon C against COVID-19?

24 Oct 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback